/Bristol-Myers%20Squibb%20Co_%20logo%20on%20phone%20by-%20Piotr%20Swat%20via%20Shutterstock.jpg)
Princeton, New Jersey-based Bristol-Myers Squibb Company (BMY) is one of the leading biopharmaceutical companies focused on developing treatments for diseases like cancer, inflammatory, immunologic, cardiovascular, and fibrotic diseases. With a market cap of $96.6 billion, Bristol-Myers’ operations span various countries in the Americas, Europe, Asia, and internationally.
The pharma giant has significantly underperformed over the past year. The BMY stock is down 21.7% over the past 52-week period, while the S&P 500 Index ($SPX) has rallied 19%. In 2024, shares of Bristol-Myers have dipped 6.1%, while the SPX has returned 14.2% on a YTD basis.
